Minerva Surgical, a U.S.-based medical device maker focused on minimally invasive alternatives to hysterectomy has filed for IPO seeking to raise up to $100M. According to documents filed with the SEC, the company has applied to list its common stock on the Nasdaq Global Stock Market under the symbol “UTRS”. Minerva has not disclosed the size of the offering or its pricing range.
Minerva was founded in 2008 and is the developer of medical devices designed to control menstrual and uterine bleeding. Its first commercialized product is Minerva ES, a PMA-approved endometrial ablation device.